With ROIC at 3.04% trailing WACC by 635 basis points, NXP's 69x EBITDA multiple prices hope over returns.
NXP's market price embeds expectations that appear divorced from the fundamental reality of a cyclical semiconductor company generating returns below its cost of capital.
What expectations are embedded in the price, and are they reasonable?
The market prices in a growth acceleration that contradicts recent performance. A 3.83% implied growth rate against negative trailing growth suggests investors expect a dramatic cyclical recovery that the framework finds improbable given current fundamentals.
Is the business creating or destroying value?
NXP systematically destroys shareholder value with returns 635 basis points below its cost of capital. The sustained negative spread since 2018 indicates this is not a temporary cycle trough but a structural profitability challenge.
How long can the company earn returns above its cost of capital?
The competitive advantage period appears exhausted given ROIC below WACC. While 17.2% R&D spending and design-win switching costs provide some moat, margin compression and concentrated revenue exposure suggest advantages are eroding rather than extending.
Is growth creating or destroying value?
Growth quality is poor — revenue declines while R&D intensity increases and working capital efficiency deteriorates. The framework sees value-destroying growth where incremental capital earns below WACC returns.
Applying this framework reveals a semiconductor company where market expectations have detached from business fundamentals. With ROIC trailing WACC by 635 basis points and the market pricing 3.83% perpetual growth against negative trailing performance, the expectations gap appears unsustainable. The framework suggests mean reversion is more probable than the growth acceleration the price implies. Does the market see a cyclical recovery invisible in current fundamentals, or has hope replaced analysis?
This analysis applies Michael Mauboussin's published investment framework to publicly available financial data. It is not authored by, endorsed by, or affiliated with Michael Mauboussin. Educational purposes only. Not financial advice.